We are live on ! Find out more
EPM

Equitec Proprietary Markets Portfolio holdings

AUM $559M
1-Year Est. Return 230.29%
This Fund
S&P 500
This Quarter Est. Return
-8.03%
1 Year Est. Return
+230.29%
3 Year Est. Return
+526.89%
5 Year Est. Return
+679.16%
10 Year Est. Return
AUM
$315M
AUM Growth
-$64.1M
Cap. Flow
-$15.6M
Cap. Flow %
-4.94%
Top 10 Hldgs %
65.01%
Holding
323
New
39
Increased
32
Reduced
45
Closed
116

Top Buys

Rank Stock Value
1
FRG
Franchise Group, Inc.
FRG
+$7.26M
2
IVV icon
iShares Core S&P 500 ETF
IVV
+$6.95M
3
TSLA icon
Tesla
TSLA
+$6.51M
4
DNA icon
Ginkgo Bioworks
DNA
+$4.13M
5
AMZN icon
Amazon
AMZN
+$3.09M

Sector Composition

Rank Sector Weight
1 Financials 15.66%
2 Industrials 13.47%
3 Technology 4.87%
4 Healthcare 2.89%
5 Consumer Discretionary 2.67%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TSEM icon
151
CALL
Tower Semiconductor
TSEM
$21.2B
$4.32K ﹤0.01%
100
GXIIW
152
DELISTED
GX Acquisition Corp. II Warrant
GXIIW
$3.95K ﹤0.01%
5,000
SOUNW icon
153
SoundHound AI Warrant
SOUNW
$526M
$3.75K ﹤0.01%
25,000
VIEWW
154
DELISTED
View, Inc. Warrant
VIEWW
$3.44K ﹤0.01%
100,200
-1,200
-1% -$73
MMVWW
155
DELISTED
MultiMetaVerse Holdings Limited Warrant
MMVWW
$3.23K ﹤0.01%
32,314
OTECW
156
DELISTED
OceanTech Acquisitions I Corp. Warrant
OTECW
$2.48K ﹤0.01%
63,700
OUSTZ
157
DELISTED
Ouster Inc Warrants
OUSTZ
$2.48K ﹤0.01%
26,122
BTWNW
158
DELISTED
Bridgetown Holdings Limited Warrants
BTWNW
$2.47K ﹤0.01%
20,000
CLVRW
159
DELISTED
Clever Leaves Holdings Inc. Warrant
CLVRW
$2.27K ﹤0.01%
64,900
SABSW icon
160
SAB Biotherapeutics Warrant
SABSW
$92.9K
$2.12K ﹤0.01%
45,000
DMS.WS
161
DELISTED
Digital Media Solutions, Inc. Warrants, each whole warrant exercisable for one Class A Ordinary Share at an exercise price of $11.50
DMS.WS
$2.11K ﹤0.01%
20,000
ARBEW icon
162
Arbe Robotics Warrant
ARBEW
$336K
$1.95K ﹤0.01%
10,000
BOXD.WS
163
DELISTED
Boxed, Inc. Warrants, each whole warrant exercisable to purchase one share of Common Stock at an exercise price of $11.50 per share
BOXD.WS
$1.95K ﹤0.01%
50,000
TMPOW
164
DELISTED
Tempo Automation Holdings, Inc. Warrant
TMPOW
$1.89K ﹤0.01%
32,000
UPH
165
PUT
DELISTED
UpHealth, Inc.
UPH
$1.63K ﹤0.01%
1,000
+900
+900% +$3.5K
ACBAW
166
DELISTED
Ace Global Business Acquisition Ltd Warrant
ACBAW
$1.55K ﹤0.01%
50,000
JSPRW icon
167
Japer Therapeutics Warrants
JSPRW
$182K
$1.38K ﹤0.01%
45,856
ADEX.WS
168
DELISTED
Adit EdTech Acquisition Corp Warrants
ADEX.WS
$1.32K ﹤0.01%
22,045
MEOAW
169
DELISTED
Minority Equality Opportunities Acquisition Inc. Warrants
MEOAW
$1.3K ﹤0.01%
20,000
PETWW
170
DELISTED
Wag! Group Co Warrant
PETWW
$1.25K ﹤0.01%
10,109
PMGMW
171
DELISTED
Priveterra Acquisition Corp. II Warrant to purchase Class A common stock
PMGMW
$720 ﹤0.01%
4,800
TCRT icon
172
Alaunos Therapeutics
TCRT
$4.64M
$664 ﹤0.01%
7
BOAC.WS
173
DELISTED
Bluescape Opportunities Acquisition Corp. Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
BOAC.WS
$640 ﹤0.01%
4,000
PGRWW
174
DELISTED
Progress Acquisition Corp. Warrant
PGRWW
$627 ﹤0.01%
10,000
BRLSW icon
175
Borealis Foods Inc Warrant
BRLSW
$590K
$600 ﹤0.01%
15,000

Similar funds

Equitec Proprietary Markets's Q4 2022 Portfolio in Review

As of Q4 2022, Equitec Proprietary Markets held 323 positions worth $315M, down 17% from $380M the previous quarter. Its ten largest holdings account for 65% of the portfolio.

Equitec Proprietary Markets withdrew a net $15.6M in Q4 2022, closing 116 positions and reducing 45 holdings. Its most notable exit was Biohaven Pharmaceutical Holding Company Ltd., an estimated $14.3M position sold in full.

By sector, the portfolio is most concentrated in Financials at 16% of assets, down from 18% a quarter earlier, followed by Industrials and Technology.

Against the trend, Equitec Proprietary Markets opened a new position in iShares Core S&P 500 ETF worth $6.92M.

  • Equitec Proprietary Markets's largest Q4 2022 buy was iShares Core S&P 500 ETF: 18,000 shares worth $6.92M.
  • Equitec Proprietary Markets added most to Franchise Group, Inc. in Q4 2022, an estimated $7.26M increase.
  • Equitec Proprietary Markets's biggest Q4 2022 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $12.3M.
  • Equitec Proprietary Markets fully exited Biohaven Pharmaceutical Holding Company Ltd. in Q4 2022, selling an estimated $14.3M.
  • Equitec Proprietary Markets's ten largest holdings make up 65% of its $315M portfolio in Q4 2022.
  • Equitec Proprietary Markets opened 39 new positions and closed 116 in Q4 2022.
  • Equitec Proprietary Markets's portfolio value fell 17% quarter-over-quarter to $315M.

Based on Equitec Proprietary Markets's 13F filing for Q4 2022, filed 31 Jan 2023.